Characterization of gene expression profiles of T cells during anti-tumor response

International Journal of Colorectal Disease

Volumn 20, Issue 6, 2005, Pages 485-493

  Stremmel, Christian ^c   Siebenhaar, Renate ^a   Croner, Roland ^a   Reingruber, Bertram ^a   Slavin, Anthony J ^b   Hohenberger, Werner ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Immunological gene profile; Microarray; T cells; Tumor immunology; Tumor resistance

Indexed keywords

B7 ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSFECTION; GENOMICS; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMOMA; TUMOR CELL; TUMOR ESCAPE; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; THYMOMA; THYMUS NEOPLASMS;

EID: 26944443612     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0714-1     Document Type: Article

References (28)

1. Rosenberg SA (1999) A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10:281-287 10.1016/ S1074-7613(00)80028-X
2. Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY (1997) The host-tumor immune conflict: From immunosuppression to resistance and destruction. Immunol Today 18:493-497 10.1016/S0167-5699(97)01115-8
3. Fink J, Ferrone S, Frey A, Mufson A, Ochoa A (1999) Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 20:158-160
4. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075-1082 10.1084/jem.184.3.1075
5. Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA (1993) Molecular mechanisms used by tumors to escape immune recognition: Immunogenetherapy and the cell biology of major histocompatibility complex class I. J Immunother 14:182-186 1:CAS:528:DyaK2cXhs1SrtbY%3D
6. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177 265-270
7. Uyttenhove C, Maryannski J, Boon T (1983) Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 157:1040-1052
8. Stremmel C, Greenfield EA, Howard E, Freeman GJ, Kuchroo VK (1999) B7-2 expressed on EL4 lymphoma suppresses anti-tumor immunity by an IL-4 dependent mechanism. J Exp Med 189:919-930
9. Zhang ZX, Yang L, Young KJ, Temple BD, Zhang L (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 7:782-789
10. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470 1:CAS:528:DyaK2MXovVersLk%3D
11. Stremmel C, Wein A, Hohenberger W, Reingruber B (2002) DNA-microarrays: a new diagnostic tool and its implications in colorectal cancer. Int J Colorectal Dis 17:131-136
12. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227-235
13. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M et al (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540
14. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68-74
15. Dürig J, Nuckel H, Huttmann A, Kruse E, Holter T, Halfmeyer K et al (2003) Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 101:2748-2755 10.1182/blood-2002-09-2683
16. Hsiao LL, Dangond F, Yoshida T, Hong R, Jensen RV, Misra J et al (2001) A compendium of gene expression in normal tissues. Physiol Genomics 7:97-104 1:CAS:528:DC%2BD38XhtFagsLs%3D
17. Teague TK, Hildeman D, Kedl RM, Mitchell T, Rees W, Schaefer BC et al (1999) Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci 22:12691-12696
18. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S et al (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889-897 1:STN:280:BiiC2cvltFI%3D
19. Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ (1990) Macrophages and cancer. Cancer Metastasis Rev 8:319-351
20. Yang JC, Mule JJ, Rosenberg SA (1986) Murine lymphokine-activated killer (LAK) cells: Phenotypic characterization of the precursor and effector cells. J Immunol 137:715-722
21. Urban JC, Schreiber H (1997) Selection of macrophage-resistant progressor tumor variants by the normal host: Requirement for concomitant T-cell mediated immunity. J Exp Med 157:642-656
22. Leibson PJ (1997) Signal transduction during natural killer cell activation: Inside a mind of a killer. Immunity 6:655-661
23. + NKT cells from tumor bearing mice, that show a natural killer cell activity and lyse multiple tumor targets. Eur J Immunol 31:2818-2828
24. Assland D, Oppmann B, Grötzinger J, Rose-John S, Kallen KJ (2002) The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex. J Mol Biol 315:637-646
25. Dinarello CA (1994) The biological properties of interleukin-1. Eur Cytokine Netw 5:517-531
26. Greenbaum LA, Horowitz JB, Woods A, Pasqualini T, Reich EP, Bottomly K (1988) Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol 140:1555-1560
27. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A (1989) Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci 86:612-616
28. Suzuki N, Yamamoto K, Toyoshima S, Osawa T, Irimura T (1996) Molecular cloning and expression of cDNA encoding human macrophage C-type lectin: its unique carbohydrate binding specificity for Tn antigen. J Immunol 156:128-135